Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,954 | -4,317 | -1,165 | -436 | 1,549 |
| Depreciation Amortization | 115 | 77 | 39 | 959 | 838 |
| Accounts receivable | -8,982 | -5,542 | -5,277 | -7,873 | -7,698 |
| Accounts payable and accrued liabilities | 2,625 | 2,700 | 2,039 | -537 | 89 |
| Other Working Capital | -5,735 | -7,280 | -4,070 | 16,943 | 16,891 |
| Other Operating Activity | 10,420 | 6,358 | 4,116 | 17,924 | 16,785 |
| Operating Cash Flow | $-6,511 | $-8,004 | $-4,318 | $26,980 | $28,454 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -13,000 | N/A |
| Common Stock Issued | 1,985 | 186 | 371 | 1,301 | 504 |
| Other Financing Activity | -161 | -111 | -12 | -1,916 | -1,907 |
| Financing Cash Flow | $1,824 | $75 | $359 | $-13,615 | $-1,403 |
| Beginning Cash Position | 26,634 | 26,634 | 26,634 | 13,269 | 13,269 |
| End Cash Position | 21,947 | 18,705 | 22,675 | 26,634 | 40,320 |
| Net Cash Flow | $-4,687 | $-7,929 | $-3,959 | $13,365 | $27,051 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,511 | -8,004 | -4,318 | 26,980 | 28,454 |
| Free Cash Flow | -6,511 | -8,004 | -4,318 | 26,980 | 28,454 |